atorvastatin has been researched along with Acute Hepatic Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrade, RJ; Carrascosa, MF; Lucena, MI; Salcines-Caviedes, JR | 1 |
| Fattinger, K; Flury, R; Kohler, M; Meier, PJ; Pauli-Magnus, C; Perger, L | 1 |
| Pelli, N; Setti, M | 1 |
3 other study(ies) available for atorvastatin and Acute Hepatic Failure
| Article | Year |
|---|---|
Acute liver failure following atorvastatin dose escalation: is there a threshold dose for idiosyncratic hepatotoxicity?
Topics: Aged, 80 and over; Atorvastatin; Chemical and Drug Induced Liver Injury; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Liver Failure, Acute | 2015 |
Fatal liver failure with atorvastatin.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Atorvastatin; Fatal Outcome; Heptanoic Acids; Humans; Liver Failure, Acute; Male; Pyrroles | 2003 |
Atorvastatin as a trigger of autoimmune hepatitis.
Topics: Antibodies, Antinuclear; Anticholesteremic Agents; Atorvastatin; Autoantibodies; Female; Hepatitis, Autoimmune; Heptanoic Acids; Humans; Liver Failure, Acute; Male; Muscle, Smooth; Pyrroles | 2004 |